Some specialties, like oncology, have been quicker to embrace the promise of pharmacogenomics (PGx), and their successes can serve as a roadmap as others explore the impact it can have on quality, outcomes and patient satisfaction.
The post PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success appeared first on MedCity News.
